VKTX
Viking Therapeutics, Inc.
Nasdaq: VKTX · San Diego, CA · Healthcare
$34.79-0.60 (-1.70%)Closed
Market Cap$4.03B
Cash$118.1Mmost recent
Runway3 mo$114.0M Q burn
P/E (TTM)—EPS $-3.19
52-Wk Range$23.09 – $42.13
Avg Volume3.7M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$34.79-46.2%
Pipeline
Drug candidates sponsored by VKTX · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for VKTX. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.